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Background: Aim of this study was to describe the outcome of patients with gingival squamous cell carcinoma 
(GSCC), and to recognize aspects affecting clinical course and to consider survival rate.
Material and Methods: The case records of patients, over a 10-year period, were retrospectively examined. Dif-
ferences in distribution of the potential risk factors by prognosis were investigated through non-parametrical tests 
(Wilcoxon Rank-Sum and Fisher’s Exact). Survival curves for age, therapy and stage were built by the Kaplan-
Meier method and compared with Log-Rank test.
Results: 79 patients were analysed. Significant increase in mortality for patients older than 77 and for those with 
advanced stages was found. Cumulative survival rate 5 years after the diagnosis was 43%, while at 10 years was 
of 11%.
Conclusions: With a statistical relationship between age and tumour stage with survival rates, and 70% of GSCC 
cases identified as stage IV, early GSCC diagnosis remains challenging.
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Introduction
Oral squamous cell carcinoma (OSCC) is the most com-
mon head and neck cancer, accounting for more than 
90% of total cases; between them, gingival squamous 
cell carcinoma (GSCC) is a rare disease, most com-
monly affecting elderly population (1,2). It represents 
usually 10% of all oral cancers in Europe and the United 
States, but in Japan, it is only second to tongue cancer, 
which remains the most common subset (3). Data about 
GSCC from Italy are lacking; last decade we reported 
one of the biggest case series of oral cancer, describing 
a prevalence of gingival involvement in about less than 
15% of total cases (4).
When separating the oral cavity into subgroups, statisti-
cal power could be lost in the final evaluation, justifying 
why authors often group the subsites together into ‘‘oral 
cancer’’; this pooling usually gives fewer data about the 
unrelated trends and possible prognosis on the subsite 
levels (5).
Despite the significant advances obtained in the diag-
nostic and therapeutic opportunities, OSCC contin-
ues to portend a modest prognosis with an estimated 
5-year overall survival rate of 56% in Western Europe 
(1). TNM stage, the grade and the depth of invasion of 
the tumour seem to have still an important effect on the 
course of the disease; nevertheless, summarizing the 
survey of the available literature data, it may be stated 
that the prognostic value of the classical clinicopatho-
logic parameters is ambiguous (6).
Recent data about gingival cancer reported a very bad 
prognosis (7,8), but Italian data are actually missing. 
The purpose of this single-center retrospective study 
was to analyse the outcome of Northern Italian patients 
with GSCC, treated by distinctive modalities, and to re-
port factors that may have affected survival rate.
Material and Methods 
From a standardised computerised database, medical 
charts of patients, with histologically confirmed diagno-
sis of GSCC, at the Oral Medicine Section (CIR-Dental 
School, Turin), over a 10-year period from June 1, 2008 
to June 1, 2018, were retrospectively examined. Sub-
jects were resident in Piedmont region, North-west Italy.
Inclusion criteria were the following: patients with his-
topathologic diagnosis of GSCC, formulated since June 
1st 2008, emerging in gingiva, and biopsied either in 
gingiva, or in edentulous ridge, or in the retromolar 
area/tuber maxillae, providing complete information on 
sex/age of the patient involved, TNM staging, and sub-
sequent follow-up, including exitus, whenever occurred.
Exclusion criteria were the following: incomplete data 
on age/sex or follow-up of patients with GSCC; lack 
of histopathologic record of GSCC; lack of TNM stag-
ing; histopathologic diagnosis of GSCC before June 1st 
2008; diagnosis of malignancies other than GSCC, such 
as verrucous carcinoma, salivary gland or mesenchy-
mal malignancy.
Demographic information, smoking (current or former 
smoker vs. non-smoker), alcohol consumption (current 
of former drinker vs. non-drinker), history of oral poten-
tially malignant disorders (OPMD), tumour site, tumour 
grade according to the WHO classification (well, mod-
erately or poorly differentiated), T classification and 
neck nodes involvement at the time of diagnosis (UICC, 
1997), staging based on the American Joint Committee 
on Cancer staging system (7th edition) (9), in situ hy-
bridization (ISH) for HPV detection performed on for-
malin-fixed, paraffin-embedded tissue using the Bond 
TM Ready-to-Use ISH HPV Probe (Leica Biosystems, 
Newcastle, UK) for the following subtypes: 16, 18, 31, 
33, 51. ISH was carried out following the manufactur-
er's instructions on the automated Leica BOND system 
(BOND-MAX, Leica Biosystems). Furthermore, treat-
ment protocols (surgery, chemotherapy, radiotherapy, 
either alone or combined) outcome and survival rate 
were also reviewed. We evaluated patient survival as of 
August 31st, 2019.
Typical follow up schedule was the same as that already 
reported (4).
A descriptive analysis was performed. Continuous vari-
ables were expressed as median and interquartile range, 
categorical variables as frequencies and percentages. 
Non-parametrical tests (Wilcoxon Rank-Sum and Fish-
er’s Exact tests for continuous and categorical variables, 
respectively) were used in order to analyse differences in 
distribution of the variables listed above by the progno-
sis. Kaplan-Meier method and Log-Rank test were used 
in order to estimate and compare survivals in different 
classes of age, therapy and stage, separately. All statistical 
analyses were performed using R software (version 3.5.3). 
Statistical significance was defined at P value of ≤0.05.
Results
Finally, 85 cases of GSCC were collected. With 6 clini-
cal charts providing insufficient clinical and/or histo-
pathologic data, 79 cases of GSCC were analysed, in 36 
men (mean age: 67.5 ± 10.6) years and 43 women (mean 
age: 73.49 ± 11.1) (Table 1), with GSCC.
Of these, 21 had previous OPMD, of which 8 (5 F;3 M) 
Oral Lichen Planus, 7 (7 F) with proliferative verrucous 
leukoplakia, and 6 (2 F; 4 M) with oral leukoplakia.
Almost 70% of total cases were identified with an ad-
vanced stage (54 patients with stage IV). Histologically, 
21 cases were identified as well differentiated, 48 as 
moderately differentiated and 10 as poorly differentiat-
ed. The mandible was more commonly affected (69.6%).
Almost 65% of the reported patients did not report the 
classical risk factors for oral cancer (e.g. tobacco and 
alcohol) (Table 1). In situ hybridization (ISH) for HPV 
revealed 5 cases resulted positive to HPV (Table 2).
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TOTAL POPULATION Total Alive# Deceased# P 
N# 79 32 47
age (median [IQR]) 73.00 [62.00, 79.50] 70.00 [57.75, 76.00] 74.00 [66.00, 82.00] .020*
Age (%) .048°
   <66 yo 26 (32.9) 14 (43.8) 12 (25.5)
   66-77 yo 26 (32.9) 12 (37.5) 14 (29.8)
   >77 yo 27 (34.2) 6 (18.8) 21 (44.7)
Male (%) 36 (45.6) 12 (37.5) 24 (51.1) .259°
Female (%) 43 (54.4) 20 (62.5) 23 (48.9) XXXX
Smokers (%) 29 (36.7) 12 (37.5) 17 (36.2) 1.00°
Drinkers (%) 11 (13.9) 2 (6.2) 9 (19.1) .184°
Comorbidities (%) .9529°
   Cardio vascular disease 42 (53.2) 17 (53.1) 25 (53.2)
   Diabetes 11 (13.9) 4 (12.5) 7 (14.9)
   Other reported malignancies 12 (15.2) 5 (15.6) 7 (14.9)
   Liver disease 5 (6.3) 1 (3.1) 4 (8.5)
   Autoimmune diseases 11 (13.9) 5 (15.6) 6 (12.8)
TOTAL POPULATION Total Alive# Deceased# P
Site of biopsy (%) .793°
 Maxillary alveolar edentulous ridge 12 (15.2) 4 (12.5) 8 (17.0)
 Mandibular alveolar edentulous ridge 19 (24.1) 8 (25.0) 11 (23.4)
 Retromolar area 17 (21.5) 6 (18.8) 11 (23.4)
 Maxillary gingiva 10 (12.7) 4 (12.5) 6 (12.8)
 Mandibular gingiva 19 (24.1) 10 (31.2) 9 (19.1)
 Tuber maxillae 2 (2.5) 0 (0.0) 2 (4.3)
Elementary lesion (%)§ .249°
   Patch 7 (8.9) 5 (15.6) 2 (4.3)
   Verrucous/node 32 (40.5) 12 (37.5) 20 (42.6)
   Ulcer/erosion 40 (50.6) 15 (46.9) 25 (53.2)
Grading (%) .504°
   1 21 (26.6) 11 (34.4) 10 (21.3)
   2 48 (60.8) 17 (53.1) 31 (66.0)
   3 10 (12.7) 4 (12.5) 6 (12.8)
HPV positive infection (%) 5 (6.3) 3 (9.3) 2 (4.2) .3899°
Of the 79 GSCC, 55 (69.6%) were located in mandible, 
whereas 24 (31.3%) in maxilla; 34 (43.3%) were de-
tected in the right side, 45 (56.7%) in the left side; 49 
(62.02%) were detected in premolar-molar regions, and 
30 (37.98%) in the incisors area. Five patients developed 
multiple malignancies: in detail, 2 patients experienced 
metachronous cancers, 1 in lower lip and 1 in side of 
tongue, respectively. On the other hand, 2 patients were 
diagnosed with synchronous cancers, 1 in fornix and 1 
in buccal mucosa. Finally, 1 patient developed both a 
synchronous tongue cancer, and two metachronous ma-
lignancies in buccal mucosa and hard palate. Primary 
tumors’ size ranged from a minimum of 9 mm in one 
patient, to a maximum diameter of 4.2 cm in one case, 
with an average size of 1.7 cm. Regarding clinical ap-
pearance, 7 (8.9%) lesions were described as patches, 
32 (40.5%) as either verrucous lesion or as submucosal 
node, with or without erosions, whereas 40 (50.6%) had 
ulcer or erosion as main clinical appearance (Fig. 1).
Ablative surgical resection was the main modality of 
treatment, and patients who presented with node posi-
tive neck disease underwent also elective neck dissec-
tion in the same way as when tumour invasion of the 
midline structure was observed. Adjuvant radiotherapy 
with local dose field of 50 to 66 Gy was used in patients 
with positive or close margins, vascular or perineural 
invasion and extracapsular spread. In detail, 23 (29.1%) 
patients underwent surgery alone, of whom 11 required 
Table 1: Main characteristics of patients with GSCCs.
Table 2: Main clinical and histopathological features of GSCCs.
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elective neck dissection; 19 (24%) were treated with a 
combination of surgery, radiotherapy and chemothera-
py; 12 (15.2%) underwent surgery and adjuvant radio-
therapy, of whom 7 required elective neck dissection; 3 
(3.8%) patients underwent surgery and chemotherapy. 
On the other hand, in 14 (17.7%) cases, considered not 
eligible for surgery, were administered either chemo-
therapy (5 cases), or radiotherapy (3 cases), or chemo/
radiotherapy (6 cases) combined. Finally, in 8 (10.1%) 
cases no treatment could be provided, due to extremely 
poor state of health already at diagnosis. (Table 3).
The median months of follow-up was of 21.00 [8.50-
61.50]. During this period, 47 (59.5%) patients died; of 
these 36 (45.5%) were GSCC-related deaths, while for 
the others it was not possible to detect the exact cause. 
The overall cumulative survival rate 5 years after the 
diagnosis was 43%, while at 10 years it was 11%.
Survival curve for GSCC according to gender, and risk 
factors smoke did not show a significant difference. 
Moreover, univariate analysis showed that age, stage 
and modality of treatment could affected the survival 
rate (p=.02, p<.0001, and p=.018 respectively) (Fig. 2).
Patients with tumours at a high T and N score had a less 
favourable prognosis than those with lower T and N val-
ues. In particular, we described 5-year survival rates of 
77% and 36% for diseases classified as stage I and stage 
IVa respectively (Table 4). The site and the grading of 
the lesions did not affect the survival rates.
The survival rates for patients treated by surgery or ra-
diotherapy (considered separately) revealed a statistical 
significance between patients treated by surgery and 
those not treated or treated without surgery.
TOTAL POPULATION Total Alive# Deceased# P 
Stage (%) .002°
   I 14 (17.7) 10 (31.2) 4 (8.5)
   II 6 (7.6) 5 (15.6) 1 (2.1)
   III 5 (6.3) 0 (0.0) 5 (10.6)
   IVa 48 (60.8) 16 (50.0) 32 (68.1)
   IVb 6 (7.6) 1 (3.1) 5 (10.6)
Treatment (%) .001°
   None 8 (10.1) 0 (0.0) 8 (17.0)
   Surgery 23 (29.1) 15 (46.9) 8 (17.0)
   Surgery plus others* 34 (43.0) 15 (46.9) 19 (40.4)
   Others* without surgery 14 (17.7) 2 (6.2) 12 (25.5)
PATIENTS TREATED WITH SURGERY Total Alive# Deceased#
N# 57 30 27
invasion 1°
Perineural invasion (%) 15 (26.3) 8 (26.6) 7 (25.9)
Extranodal invasion (%) 3 (5.3) 1 (3.3) 2 (7.4)
Positive surgical margins (%) 11 (19.3) 6 (20) 5 (18.5)
#At the end of the follow-up period; *Wilcoxon Rank-Sum’s test; °Fisher Exact’s test; *others: chemotherapy, radiotherapy or 
chemo/radiotherapy combined – see text for further specifics.
Fig. 1: GSCC arising as non-homogeneous, ulcerative mass extend-
ing from gingiva of left mandibular premolar to the surrounding 
edentulous ridge.
Table 3: Staging and treatment of GSCCs.
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Time 








60 21 2 .43 .06 .33 .57
120 1 1 .11 .08 .02 .50
VARIABLE
STAGE
   I (14 pts)
24 8 0 .93 .07 .80 1.00
60 5 1 .77 .15 .53 1.00
96 3 1 .58 .20 .29 1.00
   II (6 pts)
12 5 0 1.00 .00 1.00 1.00
60 2 0 1.00 .00 1.00 1.00
84 1 0 1.00 .00 1.00 1.00
   III (5 pts)
12 4 2 .60 .22 .29 1.00
24 1 2 .20 .18 .03 1.00
   Iva (48 pts)
12 35 12 .74 .06 .62 .88
60 13 1 .36 .07 .27 .57
108 2 1 .22 .08 .10 .047
   IVb (6 pts)
12 2 3 .44 .22 .17 1.00
60 1 0 .22 .19 .04 1.00
120 1 0 .22 .19 .04 1.00
TREATMENT 
   None (8 pts) 12 1 8 .00 NA NA NA
   Surgery (23 pts)
12 19 1 .96 .004 .88 1.00
60 10 0 .85 .09 .69 1.00
120 1 0 .34 .17 .12 .93
   Surgery plus others* (34 pts)
12 29 3 .91 .05 .81 1.00
60 9 2 .43 .09 .28 .66
108 2 1 .29 .13 .12 .71
   Others* without surgery (14 pts)
12 9 6 .56 .14 .34 .90
60 2 0 .16 .10 .04 .56
96 1 0 .08 .08 .01 .52
AGE
   <66 yo (26 pts)
12 24 2 .92 .05 .82 1.00
60 10 0 .58 .10 .42 .82
120 1 0 .49 .12 .30 .80
   66-77 yo (26 pts)
12 18 7 .72 .09 .56 .92
60 7 0 .51 .11 .34 .78
96 1 0 .32 .13 .15 .71
   >77 yo (27 pts)
12 19 I .65 .10 .49 .87
60 4 2 .22 .09 .09 .50
108 1 1 .11 .07 .003 .039
*others: chemotherapy, radiotherapy or chemo/radiotherapy combined – see text for further specifics; pts: patients.
Table 4: Data about survival rate, considering staging, treatment, age as variables. 
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Discussion
Oral cancer is a difficult disease to control, and small 
improvements have been seen in the survival rate over 
the last decades. Moreover, to the best of our knowledge, 
data about GSCC are very scarce, especially from Italy.
GSCC is an insidious disease, not always having the ap-
pearance of a malignancy, ranging from an exophytic 
to a verrucous to an ulcerated lesion, as previously 
reported by these Authors (10). Such characteristic is 
often the cause of diagnostic delay with worsening of 
the prognosis, as it can simulate periodontal inflamma-
tory pathologies or benign neoplasms (11). However, as 
previously reported by many Authors (12,13), as well 
as in a retrospective analysis of a large gingival sample 
by this group (14), GSCC represents by far the most 
common gingival malignancy to be encountered in the 
everyday clinical practice, for both specialists and non-
specialists in oral medicine.
In this study, some factors possibly having influence 
on survival were analysed. Most general features of 
the present series were coherent with previous reports. 
Squamous cell carcinoma of the head and neck is com-
monly associated with the use of alcohol and tobacco; 
however, patients diagnosed with GSCC are typically 
not exposed to classical risk factors, as confirmed in the 
present series, especially for female patient (15). More-
over, in contrast with what has been usually reported 
about oral cancer, in the present sample the survival of 
smokers is on average 44 months, compared with 32 
months for non-smokers.
According to the data collected in the present study, it 
should be necessary to pay particular attention to fe-
male patients without specific risk factors, especially 
when having flat lesions in the lower jaw. However, no 
prognostic differences emerged between males and fe-
males in the present series.
The literature reports that the GSCC most frequently 
involves the jaw in the female population aged over 
50 years; the present study sample confirms this data 
with a frequency very close to 70%, but with a decid-
edly higher onset age (73 years for females and 67.5 for 
males). However, the correlation of prognosis with age 
seems to be quite controversial. In a case-series of 450 
gingival squamous cell carcinoma, a significant influ-
ence of age distribution on prognosis was detected, with 
a 5-years survival rate of 61.7% among patients of less 
than 50 years versus 34.1% for patients above 50 years 
of age (15). Furthermore, a review of literature on oral 
carcinoma in patients twenty years of age or younger 
showed a striking predilection for gingiva, probably due 
to the high stem-cell activity of the tooth-bearing area 
(16). On the other hand, one of the widest population-
based cohorts of OSCC available in literature, with 
27717 OSCC cases scrutinized, reported lack of statisti-
cal significance between advanced staging and age, ei-
ther in gingiva or in other anatomic sites (8).
Gingival SCC presents a high possibility of periosteal 
and bone invasion due to anatomical contiguity; this 
raises the risk of metastatic dissemination (17).
The course of GSCC could be determined by specific 
factors, above all the staging of the disease. In the pres-
ent series, the set of IVa and IVb stages included almost 
70% of the total patients: this could explain the strongly 
aggressive nature of the neoplasm probably given by 
Fig. 2: Survival curve for GSCC according to age (2a), stage (2b) and 
therapy (2c) (0 = none, 1= surgery, 2 = surgery plus others, 3 = others 
without surgery).
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the close proximity to the underlying tissue layers and 
therefore the easier propensity towards invasion, in turn 
correlated to higher and earlier mortality. A series of 
334 cases of oral carcinoma, published by this group 
in 2008 (4), showed a disease-related mortality rate of 
23.2% at five years, a figure that is different from the 
current case history restricted to gingival carcinomas: 
the survival curve of the present sample shows that 
about 50% of patients died after 24 months.
To date, the treatment of GSCC remains mainly surgi-
cal, adding adjuvant radiotherapy for advanced stage 
disease or in patients at elevated risk of locoregional 
failure (4); the present data still confirmed this aspect.
Bearing in mind the limitations of a retrospective study 
conducted within a single-center on a relatively small 
sample of patients from North-West Italy, carrying a 
limited external validity, the present study, to the best 
of our knowledge, this is the biggest series of GSCC 
ever reported from Italy. We revealed age, stage and 
modality of treatment as autonomous factors in pre-
dicting survival in patients with GSCC. Carcinoma of 
the gingiva is an exception with regard to intraoral tu-
mours, not apparently associated with risk factors and 
in close contact with the underlying tissues. It presents a 
high aggressiveness and the surgical therapy, frequently 
associated with chemotherapy and radiotherapy, is of-
ten not decisive. The similarity to periodontal lesions 
or benign formations leads to a diagnostic delay with a 
sudden worsening of the prognosis. The most worrying 
element is that a high mortality rate would not seem to 
be associated with lesions of unusual localization and 
therefore of more difficult investigation, but rather lo-
cated in the gingival tissues which should be very rec-
ognizable in the daily clinical practice of dentists and 
hygienists.
With these premises, dental practitioners should play a 
fundamental role in intercepting simple colour chang-
es, especially in the gingival level, and motivating the 
patient to undergo a more thorough investigation if a 
regression of the aforementioned lesions cannot be at-
tested, especially among women in the absence of tradi-
tional risk factors.
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